Wednesday, June 20, 2018

From FDA Law Blog::

Posted: 19 Jun 2018 06:54 PM PDT
Announced as another effort to improve patient access and address drug pricing, FDA recently finalized two guidance documents intended to facilitate better communication and negotiation with payors, formulary committees, and others:
continue reading here
Post a Comment